Die transsternale Thymektomie

The transsternal thymectomy. Indication of operation and perioperative management

Summary

Between 1985 and 1998 42 transsternal thymectomies were performed. The median duration of symptoms in myasthenia gravis patients (n = 27, 25/27 patients in stadium I/II of the Ossermann classification) was 40.3 weeks and 70.8 days between first diagnosis and operation. In 12 patients a thymoma was found (11/12 patients with stadium I/II of Masaoka classification), which was associated with myasthenia gravis symptoms in 10 cases. In 3 patients thymic tumors of other origin were verified histologically. After sugery these patients have an increased risk of pulmonary complications. We changed 1996 the perioperative anesthesiological procedure using total intravenous anesthesia with propofol/remifentanil and systemic patient - controlled analgesia with piritramid in the first two days after transsternal thymectomy. This mangement allows a quick extubation after operation and improved lung function postoperatively.

Zusammenfassung

Zwischen 1985 und 1998 wurden 42 transsternale Thymektomien durchgeführt. Bei Patienten mit einer Myasthenia gravis (n = 27) betrug die durchschnittliche Dauer der Symptomatik bis zur Erstdiagnose 40,3 Wochen (25/27 Patienten in Stadium I und II nach Ossermann) und weitere 70,8 Tage bis zur operativen Therapie. Bei 12 Patienten fand sich ein Thymom (11/12 im Stadium I und II nach Masaoka), das in 10 Fällen mit einer begleitenden Myasthenia gravis Symptomatik einherging. In 3 Fällen fanden sich Thymustumore anderer Genese. In der postoperativen Phase besteht bei diesen Patienten ein erhöhtes pulmonales Risiko, das sowohl in der Narkoseführung als auch in der postoperativen Schmerztherapie berücksichtigt werden muß. Nach Umstellung des Narkoseverfahrens (1996) auf die totale intravenöse Anästhesie mit Propofol/Remifentanil und die routinemäßige Piritramid-Gabe über die PCA-Pumpe wurden keine pulmonalen Komplikationen mehr beobachtet.

Myasthenia gravis - thymoma - transsternal thymectomy - Propofol - patient-controlled analgesia

Myasthenia gravis - Thymom - transsternale Thymektomie - Propofol - Analgesie

Literatur

• 1 Ashour M H, Jain S K, Al-Daeef A Q, Abdal Jabbar M S, Al-Tahan A R. Maximal thymectomy for myasthenia gravis.  Eur J Cardiothorac Surg. 1995;  9 461-464
• 2 Beekman R, Kuks J BM, Oosterhuis H JGH. Myasthenia gravis: diagnosis and follow-up of 100 consecutive patients.  J Neurol. 1997;  244 112-118
• 3 Bertram P, Treutner K H, Winkeltau G, Schumpelik V. Chirurgische Therapie bei Myasthenia gravis und Thymom.  Chirurg. 1993;  64 796-801
• 4 Bever C T, Aquino A V, Penn A S, Lovelace R E, Rowland L P. Prognosis of ocular myasthenia.  Ann Neurol. 1983;  14 516-519
• 5 Blalock A, Mason M F, Morgan H J, Riven S S. Myasthenia gravis and tumors of the thymic region. Report of a case in which the tumor was removed.  Ann Surg. 1939;  110 554-559
• 6 Blalock A. Thymectomy in the treatment of myasthenia gravis. Report of twenty cases.  J Thorac Surg. 1944;  13 316-319
• 7 Blossom G B, Ernsthoff R M, Howells G A, Bendick P J, Glover J L. Thymectomy for Myasthenia gravis.  Arch Surg. 1998;  128 855-864
• 8 Boldt J, Thaler E, Lehmann A, Papsdorf M, Isgro F. Pain management in cardiac surgery patients: comparison between standard therapy and patient-controlled analgesia regimen. J Cardiothorac Vasc Anesth 12: 654-658
• 9 Bramis J, Pikoulis E, Leppäniemi A, Felekouras E, Alexiou D, Bastounis E. Benefits of early thymektomy in patients with Myasthenia gravis.  Eur J Surg. 1997;  163 897-902
• 10 Christensen P B, Jensen T S, Tsiropoulos I, Sørensen T, Kjær M, Højer-Pedersen E, Rasmussen M JK, Lehfeldt E. Mortality and survival in myasthenia gravis: a Danish population based study.  J Neurol Neursurg Psychiatry. 1998;  64 78-83
• 11 Cooper J D, Al-Jilaihawa A N, Pearson F G, Humphrey J G, Humphrey H E. An improved technique to facilitate transcervical thymectomy for myasthenia gravis.  Ann Thor Surg. 1988;  45 242-247
• 12 Cowen D, Hannoun-Levi J M, Resbeut M, Alzieu B. Natural history of malignant thymoma.  Oncology. 1998;  12 1001-1005
• 13 DeFilippi V J, Richmann D P, Ferguson M K. Transcervical thymectomy for myasthenia gravis.  Ann Thorac Surg. 57 194-204
• 14 Detterbeck F C, Scott W W, Howard J F, Egan T M, Keagy B A, Starek P JK, Mill M R, Wilcox B R. One hundred consecutive thymectomies for Myasthenia gravis.  Ann Thorac Surg. 1996;  62 242-245
• 15 Economopoulos G C, Lewis J W, Lee M W, Silverman N A. Carcinoid tumors of the thymus.  Ann Thorac Surg. 1990;  50 58-61
• 16 Elert O, Silber R, Schneider M. Stellenwert der Thymektomie in der Behandlung der Myasthenia gravis pseudoparalytica.  Z Herz-, Thorax-, Gefäßchirurgie. 1992;  6 99-105
• 17 Ellis K, Austin J H, Jaretzki A. Radiologic detection of thymoma in patients with myasthenia gravis.  AJR. 1988;  151 873-876
• 18 Etienne T, Deleaval P J, Megevand R. Thymoma: prognostic factors.  Eur J Cardiothorac Surg. 1993;  7 449-452
• 19 Fornasiero A, Daniele O, Ghiotto C, Piazza M, Fiore-Donati L, Calabro F, Rea F, Fiorentino M V. Chemotherapy for invasive thymoma. A 13-year experience.  Cancer. 1991;  68 30-33
• 20 Fuentes P, Leude E, Ruiz C, Bordigoni L, Thomas P, Giudicelli R, Gastaud J A, Morati N. Treatment of thymomas.  Eur J Cardiothorac Surg. 1992;  6 180-188
• 21 Fukai I, Funato Y, Mizuno T, Hashimot T, Masaoka A. Distribution of thymic tissue in the mediatinal adipose tissue.  J Thorac Cardiovasc Surg. 1991;  101 1099-1102
• 22 Gaudecker B. Functional histology of human thymus.  Anat Embryol. 1991;  183 1-15
• 23 Gripp S, Hilgers K, Wurm R, Schmitt G. Thymoma: prognostic factors and treatment outcomes.  Cancer. 1998;  83 1495-1503
• 24 Grob D, Arsura E L, Brunner N G, Namba T. The course of myasthenia gravis and therapies affecting outcome.  Ann NY Acad Sci. 1987;  505 472-476
• 25 Guth S, Nix H WA, Mayer E, Schmied W, Kramm T, Moersig W, Oelert H. Die Thymektomie bei Myasthenia gravis.  Zentralbl Chir. 1997;  122 655-660
• 26 Hatton P D, Diehl J T, Daly B D, Rheinlander B. Transsternal radical thymectomy for myasthenia gravis: a 15 year review.  Ann Thorac Surg. 1989;  47 838-844
• 27 Huang M H, King K L, Hsu W H, Huang B S, Hsu K H, Wang L S, Chien K Y. The outcome of thymectomy in non-thymomatous myasthenia gravis.  Surg Gynecol Obstet. 1988;  166 436-440
• 28 Inderbitzi R, Rösler K, Nachbur B. Die transsternale Thymektomie bei der Myasthenia gravis.  Chirurg. 1991;  62 474-480
• 29 Ishimura H, Sata H, Matsumoto T, Takizuha A, Shigematsu A. Anesthetic management of a patient with myasthenia gravis during hypothermic cardiopulmonary bypass.  J Clin Anesth. 1998;  10 228-231
• 30 Jaretzki A, Penn A S, Younger D S, Wolff M. „Maximal” thymektomy for myasthenia gravis. Results.  J Thorac Cardiovasc Surg. 1988;  95 747-757
• 31 Jaretzki A, Wolff M. Maximal thymektomy for myasthenia gravis. Surgical anatomy and operative technique.  J Thorac Cardiovasc Surg. 198?;  96 711-716
• 32 Kirschner P A. Reoperation for thymoma: a report of 23 cases.  Ann Thorac Surg. 1990;  49 550-555
• 33 Lansak D J. Indications for thymectomy in myasthenia gravis.  Neurology. 1990;  40 1826-1829
• 34 Lehmann A, Boldt J, Zeitler C, Thaler E, Werling C. Total intravenous anesthesia with remifentanil and propofol for implantation of cardioverter-defibrillator in patients with severely reduced left ventricular function.  J Cardiothorac Vasc Anesth. 1999;  13 15-19
• 35 Lewis R A, Selwa J F, Lisak R P. Myasthenia gravis: immunological mechanisms and immunotherapy.  Ann Neurol. 1995;  37 (Suppl 1) S 51-S 62
• 36 Link H, Olsson O, Sun J. Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls.  J Clin Invest. 87 1291-1295
• 37 Lorimer M, Hall R. Remifentanil and propofol total intravenous anaesthesia for thymectomy in myasthenia gravis.  Anaesth Intensive Care. 1998;  26 210-212
• 38 Mack M J, Landreneau R J, Yim A P, Hazelrigg S R, Scruggs G R. Results of video-assisted thymectomy in patients with myasthenia gravis.  J Thorac Cardiovasc Surg. 1996;  112 1352-1360
• 39 Maggi G, Casadio C, Cavallo A, Cianci R, Molinatti M, Ruffini E. Thymoma: results of 241 operated cases.  Ann Thorac Surg. 1991;  51 152-156
• 40 Maggi G G, Donadio M, Ciuffreda L. Thymomas. A review of 169 cases, with particular reference to results of surgical treatment.  Cancer. 1986;  58 765-776
• 41 Mantegazza R, Beghi E, Pareyson P, Antozzi C, Peluchetti D, Sghirlanzoni A, Cosi V, Lombardi M, Piccolo G, Tonali P, Evoli A, Ricci E, Batocchi A P, Angelini C, Micaglio G F, Marconi G, Taiuti R, Bergamini L, Durelli L, Cornelio F. A multicenter follow-up study of 1 152 patients with myasthenia gravis in Italy.  J Neurol. 1990;  237 339-344
• 42 Masoaka A, Yamakawa Y, Niwa H, Fukai I, Kondo S, Koboyashi M, Fujii Y, Mondem Y. Extended thymectomy for myasthenia gravis patients: a 20-years-review.  Ann Thorac Surg. 1996;  3 853-859
• 43 Masaoka H, Monden Y, Seike Y, Tanioka T C. Follow-up study of thymomas with special reference to their clinical stages.  Cancer. 1981;  48 2485-2491
• 44 Masaoka A, Nagaoka Y, Kotke Y. Distribution of thymic tissue at the anterior mediastinum. Current procedure in thymectomy.  J Thorac Cardiovasc Surg. 1975;  70 747-754
• 45 Matsuzaki Y, Tomita M, Shibata K. Influence of age on extended thymectomy as a treatment for myasthenia gravis.  Ann Thorac Cardiovasc Surg. 1998;  4 192-195
• 46 Mönig S P, Türler A, Raab M. Transsternale Thymektomie bei Myasthenia und Thymom.  Zentralbl Chir. 1992;  120 963-968
• 47 Molnar J, Szobor A. Myasthenia gravis: Effect of thymectomy in 425 patients - a 15 year experience.  Eur J Cardiothorac. 1990;  4 8-14
• 48 Morlion B, Ebner E, Weber A, Finke W, Puchstein C. Influence of bolus sizes on efficacy of postoperative patient-controlled analgesia with piritramide.  Br J Anaesth. 1999;  82 52-55
• 49 Mulder D G, Graves M, Hermann C. Thymektomie for myasthenia gravis. Recent observations and comparisons with past experience.  Ann Thorac Surg. 1989;  48 551-557
• 50 Nakahara K, Ohno K, Hashimoto J, Meada H, Miyoshi S, Sakurai M, Monden Y, Kawashima Y. Thymoma: results with complet resection and adjuvant postoperative irradiation in 141 consecutive patients.  J Thorac Cardiovasc. 1988;  95 1041-1047
• 51 Nakamura H, Taniguchi Y, Suzuki Y, Tanaka Y, Ishiguro K, Fukuda M, Hara H, Mori T. Delayed remission for Myasthenia gravis of the purely ocular type.  J Thorac Cardiovasc Surg. 1996;  112 371-375
• 52 Nicolaou S, Müller N L, Li D KB, Oger J JF. Thymus in myasthenia gravis: Comparison of CT and pathologic findings and clinical outcome after thymectomy.  Radiology. 1996;  201 471-474
• 53 Nix W A. Indikationen und Nutzen der Thymektomie bei Myasthenia gravis.  Nervenarzt. 1997;  68 85-89
• 54 Nussbaum M S, Rosenthal G J, Samaha F J, Grinvalsky H T, Quinla J G, Schmerler M, Fischer J E. Management of myasthenia gravis by extendes thymectomy with anterior mediastinal dissection.  Surgery. 1992;  112 681-688
• 55 Oh S J, Kim D E, Kuruoglu R, Bradley R J, Dweyer D. Diagnostic sensitivity of the laboratory tests in myasthenia gravis.  Muscle Nerve. 1992;  15 720-724
• 56 Ohlmer A, Leger R, Scheiderer U, Elfeldt R, Wulf H. Pain therapy after thoracotomies - systemic patient-controlled analgesia (PCA) with opioid versus intercostl block and interpleural analgesia.  Anaesthesiol Reanim. 1997;  22 159-163
• 57 Olanow C W, Wechsler A S, Roses A D. A prospective study of thymectomy and serum acetylcholine receptor antibodies in myasthenia gravis.  Ann Surg. 1982;  196 113-121
• 58 Oosterhuis H JGH. Long-term effects in treatment in 374 patients with myasthenia gravis.  Monogr Allergy. 1988;  25 75-85
• 59 Oosterhuis H JGH. The natural course of myasthenia gravis: a long term follow up study.  J Neurol Neurosurg Psychiatry. 1989;  52 1221-1227
• 60 Ossermann K E, Genkins G. Studies in myastenia gravis: review of a twenty-year experience in over 1 200 patients.  MT Sinai J Med. 1971;  38 497-513
• 61 Osterhuis H J. Observation of the natural history of myasthenia gravis and the effect of thymectomy.  Ann NY Acad Sci. 1981;  377 678-682
• 62 Palmasani M T, Evoli A, Batocchi A P, Provenzano C, Tonali P. Myasthenia gravis associated with thymoma: clinical characteristic and long-term outcome.  Eur Neurol. 1994;  34 78-82
• 63 Papatestas A E, Genkins G, Kornfeld P. Effects of thymectomy in Myasthenia gravis.  Ann Surg. 1987;  206 79-88
• 64 Regnard J F, Magdeleinat P, Dromer C, Dulmet E, De Montpreville V, Levi J F, Levasseut P. Prognostic factors and long-term results after thymoma resection: a series of 307 patients.  J Cardiovasc Surg. 1996;  112 376-384
• 65 Rhodes M, Conacher I, Morritt G, Hilton C. Nonsteroidal antiinflammatory drugs for postthoracotomy pain. A prospective controlled trial after lateral thoracotomy.  J Thorac Cardiovasc Surg. 1992;  103 17-20
• 66 Rosai T, Higa E. Mediastinal endocrine neoplasm of probably thymic origin, related to carcinoi tumor: clinicopathologic study of 8 cases.  Cancer. 1972;  29 1061-1074
• 67 Sabbagh M N, Garza J S, Patten B. Thoracoscopic thymectomy in patients with myasthenia gravis.  Muscle Nerve. 1995;  18 1475-1480
• 68 Rückert J C, Gellert K, Einhäupl K, Müller J M. Die thorakoskopische Thymektomie zur Behandlung der Myasthenia gravis.  Zentralbl Chir. 1998;  123 506-511
• 69 Sarkar M R, Bähr R, Mastragelopulos N. Operative Therapie bei Thymuserkrankungen.  Chir Praxis. 1993;  46 13-22
• 70 Sauerbruch F. Die Eröffnung des vorderen Mittelfellraumes. In: Bruns P v (Hrsg) Beiträge zur klinischen Chirurgie Bd 77, S.1; Enke, Stuttgart 1912
• 71 Schneider P M, Fellbaum C, Fink U, Bollschweiler E, Pracuer H W. Prognostic importance of histomorphologic subclassification for epithelial thymic tumor.  Ann Surg Oncol. 1997;  4 46-56
• 72 Schulze W, Laczkovics A, Richter J, Sindern E. Thymektomie bei Myasthenia gravis - eine Standortanalyse.  Chirurg. 1998;  69 1345-1351
• 73 Schumm F, Wiethölter H, Fateh-Maghadaam A, Dichgans J. Thymectomy in myasthenia gravis with pure ocular symptoms.  J Neurol Neurosurg Psychiatry. 1985;  48 332-337
• 74 Sörensen T T, Holm E B. Myasthenia gravis in the country of Viborg.  Eur Neurol. 1989;  29 177-179
• 75 Späth G, Inninger R, Huth Ch, Laberke H G, Hoffmeister H E. Thymome - Eine retrospektive Studie über 48 Fälle.  Chirurg. 1997;  58 529-536
• 76 Speicher A, Jessberger J, Braun R, Hollnberger H, Stigler F, Manz R. Postoperative pulmonary function after lung surgery. Total intravenous anaesthesia with propofol in comparison to balanced anesthesia with isoflurane.  Anaesthesist. 1995;  44 265-273
• 77 Sugarbaker D J. Thoracoscopy in the management of anterior mediastinal masses.  Ann Thorac Surg. 1993;  56 653-656
• 78 Teh B T, McArdle J, Menon J, Hartley L, Pullan P, Ho J, Khir A, Wilkinson S, Larsson C, Cameron D, Sheperd J. Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1.  Medicine. 1997;  76 21-29
• 79 Tommasi R M, Garcia A R, Vivo M, Nunez M, Grau F. Cardiocirculatory stability and early extubation in patients undergoing thoracic surgery with propofol as the single anesthetic agent.  Minerva Anesthesiol. 1995;  61 183-189
• 80 Wang L S, Huang M H, Lin T S, Huang B S, Chien K Y. Malignant Thymoma.  Cancer. 70 443-450
• 81 Wick M R, Bernatz B E, Carney J A, Brown L R. Primary mediastinal carcinoid tumors.  Am J Surg Pathol. 1982;  6 195-205
• 82 Wolff H, Naundorf M. Diagnostik und Therapie von Thymustumoren.  Zentralbl Chir. 1991;  116 3-13